T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Cardiovascular Medicine

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2459/JCM.0000000000000195PMID 25252038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

  2015cited by this paper
• The universal definition of myocardial infarction

  2015cited by this paper
• Association between the atrial natriuretic peptide rs5065 gene polymorphism and the presence and severity of coronary artery disease in an Iranian population

  2014cited by this paper
• Sex‐based differences in cardiac ischaemic injury and protection: therapeutic implications

  2014cited by this paper
• Age and clinical outcomes in patients presenting with acute coronary syndromes.

  2013cited by this paper
• C2238 Atrial Natriuretic Peptide Molecular Variant Is Associated With Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling

  2013cited by this paper
• Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2013cited by this paper
• Atrial Natriuretic Peptide Genetic Variant rs5065 and Risk for Cardiovascular Disease in the General Community: A 9-Year Follow-Up Study

  2013cited by this paper
• Age-Specific Trends in Morbidity, Mortality and Case-Fatality from Cardiovascular Disease, Myocardial Infarction and Stroke in Advanced Age: Evaluation in the Swedish Population

  2013cited by this paper
• Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.

  2012cited by this paper
• Association of 2238T>C polymorphism of the atrial natriuretic peptide gene with coronary artery disease in Afro-Caribbeans with type 2 diabetes.

  2012cited by this paper
• Socioeconomic environment and recurrent coronary events after initial myocardial infarction.

  2012cited by this paper
• Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.

  2012cited by this paper
• Mortality Rate Increases Steeply With Nonadherence to Statin Therapy in Patients With Acute Coronary Syndrome

  2012cited by this paper
• Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort.

  2011cited by this paper
• Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes.

  2011cited by this paper
• [Cardiovascular epidemiologic observatory 2008-2011: preliminary results].

  2010cited by this paper
• NT-proANP/ANP is a Determinant of Vascular Damage in Humans

  2010cited by this paper
• [Cardiovascular Epidemiologic Observatory: temporal trends of cardiovascular risk factors].

  2010cited by this paper
• Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro

  2009cited by this paper
• A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae

  2009cited by this paper
• Pharmacogenetic Association of the NPPA T2238C Genetic Variant With Cardiovascular Disease Outcomes in Patients With Hypertension

  2009cited by this paper
• Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.

  2008cited by this paper
• Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.

  2008cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• Comparison of methods for analyzing recurrent events data: application to the Emergency Department Visits of Pediatric Firearm Victims.

  2007cited by this paper
• Prior Calcium Channel Blockade and Short-Term Survival Following Acute Myocardial Infarction

  2004cited by this paper
• Atrial Natriuretic Peptide Gene Polymorphisms and Risk of Ischemic Stroke in Humans

  2004cited by this paper
• Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease.

  2003cited by this paper
• Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization.

  1999cited by this paper
• The world health organization—International society of hypertension blood pressure lowering treatment trialists’ collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments

  1999cited by this paper
• Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction

  1997cited by this paper
• Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.

  1997cited by this paper
• Regression with frailty in survival analysis.

  1991cited by this paper
• Regression with frailty in survival analysis.

  1991cited by this paper

• Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks

  2025cites this paper
• Atrial natriuretic peptide T2238C gene polymorphism and the risk of cardiovascular diseases: A meta‑analysis.

  2024cites this paper
• A State of Natriuretic Peptide Deficiency

  2022cites this paper
• The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases

  2018cites this paper
• T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients

  2018cites this paper
• C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP

  2017cites this paper
• Association of Polymorphisms in the Atrial Natriuretic Factor Gene with the Risk of Essential Hypertension: A Systematic Review and Meta-Analysis

  2016cites this paper
• ScaI atrial natriuretic peptide gene polymorphisms and their possible association with postoperative atrial fibrillation – a preliminary report

  2016cites this paper
• Red cell distribution Width (RDW) and Increased Risk of Recurrent Acute Coronary Syndrome

  2015cites this paper
• C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro

  2015cites this paper
• The C2238/αANP Variant Is a Negative Modulator of Both Viability and Function of Coronary Artery Smooth Muscle Cells

  2014cites this paper